These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 6090177)
1. Human platelet alpha 2-adrenoceptors: relationship between radioligand binding studies and adrenaline-induced aggregation in normal individuals. Swart SS; Pearson D; Wood JK; Barnett DB Eur J Pharmacol; 1984 Aug; 103(1-2):25-32. PubMed ID: 6090177 [TBL] [Abstract][Full Text] [Related]
2. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation. Lanza F; Cazenave JP Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964 [TBL] [Abstract][Full Text] [Related]
3. Labelling of human platelet alpha 2-adrenoceptors with the full agonist [3H](-)adrenaline. Garcia-Sevilla JA; Fuster MJ Eur J Pharmacol; 1986 May; 124(1-2):31-41. PubMed ID: 3013661 [TBL] [Abstract][Full Text] [Related]
4. Alpha 2-adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human platelets. Swart SS; Maguire M; Wood JK; Barnett DB Eur J Pharmacol; 1985 Oct; 116(1-2):113-9. PubMed ID: 2996911 [TBL] [Abstract][Full Text] [Related]
6. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine. Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579 [TBL] [Abstract][Full Text] [Related]
7. Characterization of alpha 2-adrenoceptors on blood platelets from various species using 3H-yohimbine. Glusa E; Markwardt F Haemostasis; 1983; 13(2):96-101. PubMed ID: 6307838 [TBL] [Abstract][Full Text] [Related]
8. Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan. Galitzky J; Senard JM; Lafontan M; Stillings M; Montastruc JL; Berlan M Br J Pharmacol; 1990 Aug; 100(4):862-6. PubMed ID: 1976403 [TBL] [Abstract][Full Text] [Related]
9. Functional significance of the platelet alpha2-adrenoceptor: studies in patients with myeloproliferative disorders. Swart SS; Pearson D; Wood JK; Barnett DB Thromb Res; 1984 Mar; 33(5):531-41. PubMed ID: 6326344 [TBL] [Abstract][Full Text] [Related]
10. Alpha-2-adrenoreceptor density on intact platelets and adrenaline-induced platelet aggregation in endurance- and nonendurance-trained subjects. Lehmann M; Hasler K; Bergdolt E; Keul J Int J Sports Med; 1986 Jun; 7(3):172-6. PubMed ID: 3015811 [TBL] [Abstract][Full Text] [Related]
11. Alpha 2-adrenergic receptors on canine platelet membranes characterized by [3H]-yohimbine binding. O'Hara N; Yokota S; Kouchi Y; Ono H Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):179-94. PubMed ID: 3012728 [TBL] [Abstract][Full Text] [Related]
12. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation. Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942 [TBL] [Abstract][Full Text] [Related]
13. Atipamezole, an imidazoline-type alpha(2)-adrenoceptor inhibitor, binds to human platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine. Mustonen P; Savola J; Lassila R Thromb Res; 2000 Aug; 99(3):231-7. PubMed ID: 10942789 [TBL] [Abstract][Full Text] [Related]
14. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients. Brodde OE; Daul A; O'Hara N; Bock KD J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731 [TBL] [Abstract][Full Text] [Related]
15. [3H]-RS-15385-197, a selective and high affinity radioligand for alpha 2-adrenoceptors: implications for receptor classification. MacKinnon AC; Kilpatrick AT; Kenny BA; Spedding M; Brown CM Br J Pharmacol; 1992 Aug; 106(4):1011-8. PubMed ID: 1327384 [TBL] [Abstract][Full Text] [Related]
16. Interaction between amitraz and alpha 2-adrenoceptors inhibits epinephrine-induced canine platelet aggregation. Koeiman NR; Hsu WH Arch Int Pharmacodyn Ther; 1991; 310():56-65. PubMed ID: 1663333 [TBL] [Abstract][Full Text] [Related]
17. Platelet alpha 2-adrenoceptors and diurnal changes of platelet aggregability in hypertensive patients. Mores N; Martire M; Pistritto G; Volpe AR; Menini E; Folli G; Cardillo C J Hypertens; 1994 Aug; 12(8):939-45. PubMed ID: 7814853 [TBL] [Abstract][Full Text] [Related]
18. Binding of [3H]-p-aminoclonidine to alpha 2-adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes. Piletz JE; Andorn AC; Unnerstall JR; Halaris A Biochem Pharmacol; 1991 Jul; 42(3):569-84. PubMed ID: 1677571 [TBL] [Abstract][Full Text] [Related]
19. Altered adrenoceptor responsiveness during adrenaline infusion but not during mental stress: differences between receptor subtypes and tissues. Larsson PT; Martinsson A; Olsson G; Hjemdahl P Br J Clin Pharmacol; 1989 Dec; 28(6):663-74. PubMed ID: 2558700 [TBL] [Abstract][Full Text] [Related]
20. O-Methylated and sulfoconjugated catecholamines: differential activities at human platelet alpha 2-adrenoceptors. Lenz T; Werle E; Strobel G; Weicker H Can J Physiol Pharmacol; 1991 Jul; 69(7):929-37. PubMed ID: 1683267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]